Biology 9700 · AS & A Level · Genetic technology applied to medicine

Genetic technology applied to medicine — practice question

Adenosine deaminase (ADA) deficiency is an immune-system disorder arising from a recessive autosomal mutation. The severe combined immunodeficiency caused by a lack of ADA is called ADA-SCID.
(a)[4]

Outline the main principles involved in genetic engineering.

(b(i))[2]

Explain why a single infusion of gene-corrected stem cells is sufficient to cure the disease.

(b(ii))[2]

Explain why a promoter has to be transferred along with the desired gene.

(b(iii))[2]

A modified retrovirus is used to place the new gene into the DNA of the blood stem cells. State two ethical considerations of using a retrovirus for gene therapy.

(c)[3]

The gene therapy method used to cure ADA-SCID is not suitable for treating the genetic disorder called Huntington’s disease. A newer technique called gene editing could potentially be used instead to cure Huntington’s disease. Explain why gene editing is more suitable as a potential cure for Huntington’s disease.

Worked solution & mark scheme

This 13-mark question has a full step-by-step worked solution and mark scheme. One marking point: insert DNA to produce a new named characteristic or protein

  • Full mark scheme, point by point
  • Step-by-step worked solution
  • Write your answer & get it marked instantly by AI